Xenon Pharmaceuticals Inc (XENE) — Defensive Interval Ratio
Xenon Pharmaceuticals Inc (XENE) has a Defensive Interval Ratio of 3066 days as of December 2025. Defensive assets of $351.09 Million (cash $-, short-term investments $349.72 Million, receivables $1.37 Million) cover 3066 days of daily cash needs of $114.50K/day. See XENE current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Xenon Pharmaceuticals Inc Defensive Interval Ratio (2012–2025)
This chart shows how Xenon Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 14 annual periods from 2012 to 2025. As of December 2025, the ratio stands at 3066 days, meaning defensive assets of $351.09 Million can fund 3066 days of operations without new revenue. See debt-free asset ratio of Xenon Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Xenon Pharmaceuticals Inc (2012–2025)
The table below presents the year-by-year Defensive Interval Ratio for Xenon Pharmaceuticals Inc from 2012 to 2025, covering 14 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see XENE market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3066 days | $351.09 Million | $114.50K/day | $- | $349.72 Million | ▼ -1914 days |
| 2024 | 4981 days | $485.66 Million | $97.51K/day | $- | $484.19 Million | ▼ -1581 days |
| 2023 | 6562 days | $490.31 Million | $74.72K/day | $- | $489.44 Million | ▼ -2053 days |
| 2022 | 8615 days | $535.83 Million | $62.20K/day | $- | $534.85 Million | ▼ -1040 days |
| 2021 | 9655 days | $378.85 Million | $39.24K/day | $- | $376.09 Million | ▲ +6351 days |
| 2020 | 3304 days | $133.81 Million | $40.50K/day | $- | $131.99 Million | ▲ +2316 days |
| 2019 | 988 days | $117.42 Million | $118.85K/day | $- | $116.60 Million | ▼ -3603 days |
| 2018 | 4591 days | $51.81 Million | $11.28K/day | $- | $51.55 Million | ▲ +2479 days |
| 2017 | 2111 days | $23.62 Million | $11.19K/day | $- | $23.18 Million | ▼ -2794 days |
| 2016 | 4905 days | $47.25 Million | $9.63K/day | $- | $47.05 Million | ▲ +4864 days |
| 2015 | 41 days | $315.00K | $7.62K/day | $- | $0.00 | ▼ -271 days |
| 2014 | 312 days | $12.23 Million | $39.14K/day | $- | $12.02 Million | ▲ +77 days |
| 2013 | 236 days | $11.77 Million | $49.87K/day | $- | $11.33 Million | ▲ +228 days |
| 2012 | 7 days | $392.00K | $52.59K/day | $- | $- | — |